Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cannabidiol for Carpal Tunnel Syndrome
NCT06108349Phase 2Not yet recruiting
- Sponsor
- University of Virginia
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cannabidiol in carpal tunnel syndrome (CTS), sponsored by University of Virginia. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT06108349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06108349.